首页> 外国专利> ANTITUMOR AGENT, SELECTIVE CYTOTOXIC AGENT FOR HUMAN TUMOR CELL, MICROBIAL STRAIN PRODUCING HEPTELIDIC ACID CHLOROHYDRIN AND ITS PRODUCTION

ANTITUMOR AGENT, SELECTIVE CYTOTOXIC AGENT FOR HUMAN TUMOR CELL, MICROBIAL STRAIN PRODUCING HEPTELIDIC ACID CHLOROHYDRIN AND ITS PRODUCTION

机译:抗肿瘤剂,人类肿瘤细胞选择性细胞毒剂,微生物菌种生产丙二酸氯氢苷及其生产

摘要

PURPOSE: To provide an antitumor agent containing heptelidic acid chlorohydrin, having high antitumor activity and exhibiting selective cytotoxic action on human tumor cell. ;CONSTITUTION: This antitumor agent contains the compound of formula or its salt and a pharmacologically permissible carrier as active components. It can be prepared in the form of oral administration agent or parenteral administration agent by conventional method and is administered at a daily rate of 0.01-10mg/kg for parenteral administration and 0.5-20mg/kg for oral administration. The compound of formula can be produced by culturing Acremonium sp. No.618 (a microbial strain belonging to the genus Acremonium and capable of producing heptelidic acid chlorohydrin) in a medium and separating the heptelidic acid chlorohydrin produced and accumulated in the cultured product. The agent exhibits high injuring action exclusively on tumor cells at a low concentration compared with conventional chemotherapeutic agent.;COPYRIGHT: (C)1995,JPO
机译:目的:提供一种含有庚二酸氯醇的抗肿瘤剂,该抗肿瘤剂具有高的抗肿瘤活性并且对人肿瘤细胞具有选择性的细胞毒作用。 ;组成:该抗肿瘤药含有式化合物或其盐和可药用载体作为活性成分。可以通过常规方法以口服给药剂或肠胃外给药剂的形式制备,并且肠胃外给药的日剂量为0.01-10mg / kg,口服给药的日剂量为0.5-20mg / kg。式(I)的化合物可以通过培养顶头孢霉(Acremonium sp。)而产生。 No.618(属于顶孢属的微生物菌株,其能够产生庚二酸氯醇)在培养基中,并且分离在培养产物中产生并积累的庚二酸氯醇。与常规化学治疗剂相比,该药物在低浓度下仅对肿瘤细胞具有高损伤作用。;版权所有:(C)1995,JPO

著录项

  • 公开/公告号JPH07277971A

    专利类型

  • 公开/公告日1995-10-24

    原文格式PDF

  • 申请/专利权人 KOBE STEEL LTD;

    申请/专利号JP19940065223

  • 申请日1994-04-01

  • 分类号A61K31/365;C12P17/08;

  • 国家 JP

  • 入库时间 2022-08-22 04:26:41

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号